跳至主要内容
临床试验/TCTR20180130001
TCTR20180130001招募中4 期

Benefits and safety of high flow nasal oxygen in mild to moderate acute hypoxemic respiratory failure at medical ward, a randomized trial

no0 个研究点目标入组 60 人开始时间: 2018年1月30日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 Years(—)
性别
All

入选标准

  • all the following
  • 1.Mild to moderate acute hypoxemic respiratory failure(table)
  • 2.Admitted at general medical wards
  • 3.Age >18 years old
  • Definition of mild to moderate hypoxemic respiratory failure
  • •Respiratory rate >25 breaths/min and/or increased work of breathing, evidenced by clinical signs (dyspnea, use of accessory muscles of respiration, diaphoresis) AND
  • •Requiring >4 L/min O2 via nasal cannula or requiring O2 therapy equivalent to
  • FiO2 >0.4 to keep PaO2 >60 mmHg or SpO2 >90% for >1 hour

排除标准

  • 1.PaCO2 >45 mmHg
  • 2.Post-extubation respiratory failure (respiratory failure within 48 hr after extubation)
  • 3.Life-threatening ARF requiring immediate IMV
  • 5.Contraindications to NIV
  • 6.A do-not-intubate order
  • 7.Patients refused to participate the study
  • 8.Intra-abdominal hypertension
  • 9.Pulmonary tuberculosis

研究者

发起方
no

相似试验